Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome
The DOI matches its Crossref record; 196 of the 200 references it cites were found in a registry or an index.
Abstract
Nonclassic congenital adrenal hyperplasia (NCAH) is one of the most frequent autosomal recessive disorders in man with a prevalence ranging from 0.1 % in Caucasians up to a few percent in certain ethnic groups. Most cases are never diagnosed due to very mild symptoms, misdiagnosing as polycystic ovary syndrome, or ignorance. In contrast to classic CAH, patients with NCAH present with mild partial cortisol insufficiency and hyperandrogenism and will survive without any treatment. Undiagnosed NCAH may result in infertility, miscarriages, oligomenorrhea, hirsutism, acne, premature pubarche, testicular adrenal rest tumors, adrenal tumors, and voice problems among other symptoms. A baseline measurement of 17-hydroxyprogesterone can be used for diagnosis, but the ACTH stimulation test with measurement of 17-hydroxyprogesterone is regarded as the golden standard. The diagnosis can be verified by CYP21A2 mutation analysis. Treatment is symptomatic and usually with glucocorticoids alone. The lowest possible glucocorticoid dose should be used. Long-term treatment with glucocorticoids will improve the symptoms but will also result in iatrogenic cortisol insufficiency and may also lead to long-term complications such as obesity, insulin resistance, hypertension, osteoporosis, and fractures. Although the complications seen in NCAH patients have been assumed to be related to the glucocorticoid treatment, some may, in fact, be associated with prolonged hyperandrogenism. Different risk factors and negative consequences should be monitored regularly in an attempt to improve the clinical outcome. More research is needed in this relatively common disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, these individuals typically have normal basal cortisol and aldosterone production but mildly elevated levels of adrenal androgens; however, suboptimal cortisol levels after ACTH stimulation are reported in up to 30% of patients (37).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [37]
In the citing paper
“but in contrast to classic CAH, central precocious puberty is infrequently observed (37).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [37]
In the citing paper
“Nonclassical adrenal hyperplasia is a milder and later (adult) onset variant of classical congenital adrenal hyperplasia (48) with a much higher but still rare population prevalence (1:1000 vs 1:16,000 for the classical variant) (49).”
From Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance (2018) · cites this paper as [48]
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“the clinical presentation of PCOS and NCAH can be identical [18, 19]; thus, in order to diagnose PCOS, it is a prerequisite that the latter has been excluded [20].”
BackgroundSpeiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Heart rate and cardiovascular mortality: The Framingham study
Kannel, W. B., Kannel, C., Paffenbarger, R. S., & Cupples, L. A. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90666-1 · Cited by 1,290
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669 · cited 10×
“0 nmol/L in adults has been suggested to exclude CAH [6, 31].”
BackgroundInfluentialCongenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
High frequency of nonclassical steroid 21-hydroxylase deficiency.
Speiser, P., Dupont, B., Rubinstein, P., Piazza, A., Kaštelan, A., & New, M. I. (1985) · PubMed Central · Cited by 537
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458 · cited 1×
“During childhood, hydrocortisone is the preferred choice due to the potential growth suppression of longer-acting preparations [58].”
BackgroundCongenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
New, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365 · cited 5×
“Occasional patients with the NCAH phenotype have been reported to have an SW or SV genotype [14, 48].”
BackgroundInfluentialMulaikal, R. M., Migeon, C. J., & Rock, J. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701223160402 · Cited by 361
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344 · cited 1×
“5 million newborns [6, 34–36].”
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., & New, M. I. (2008) · Archives of Sexual Behavior · doi:10.1007/s10508-007-9265-1 · Cited by 326
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313 · cited 9×
“In contrast, one study showed that children with classic CAH were more likely to have increased blood pressure compared to NCAH children [12].”
BackgroundResultInfluentialSex steroids and insulin resistance
LIVINGSTONE, C., & COLLISON, M. (2002) · Clinical Science · doi:10.1042/cs1020151 · Cited by 309 · cited 1×
“Supraphysiological glucocorticoid doses are often claimed to be the reason for insulin resistance in CAH, but high androgen levels in females and low testosterone levels in males can result in insulin resistance [138, 139].”
BackgroundStikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305
White, P. C., New, M. I., & Dupont, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7505 · Cited by 292 · cited 1×
“gene encoding the 21-hydroxylase enzyme affected in CAH patients with 21-hydroxylase deficiency was reported [3].”
BackgroundFrisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276
Self-citationTusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254 · cited 1×
“NCAH typically has 20–50 % residual 21-hydroxylase enzyme activity [7], leading to androgen excess [8], but also a mild cortisol and, to some extent, aldosterone deficiency [9].”
BackgroundAzziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244 · cited 1×
“0 nmol/L in adults has been suggested to exclude CAH [6, 31].”
Backgroundde Vries, A., Holmes, M. C., Heijnis, A., Seier, J. V., Heerden, J., Louw, J., Wolfe-Coote, S., Meaney, M. J., Levitt, N. S., & Seckl, J. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30982 · Cited by 241
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins
Wiegratz, I., Kutschera, E., Lee, J. H., Moore, C., Mellinger, U., Winkler, U. H., & Kuhl, H. (2003) · Contraception · doi:10.1016/s0010-7824(02)00436-5 · Cited by 239 · cited 1×
“Oral contraceptive pills inhibit androgen synthesis in the ovaries and increase the production of SHBG from the liver, resulting in a 40–60 % decrease in testosterone levels [66].”
BackgroundHirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., Wedell, A., & Lajic, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1340 · Cited by 228
Self-citationAdrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227
Newborn screening for congenital adrenal hyperplasia
Therrell, B. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70017-3 · Cited by 221
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213
Setji, T. L., Holland, N. D., Sanders, L. L., Pereira, K. C., Diehl, A. M., & Brown, A. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2774 · Cited by 210 · cited 6×
“NCAH is a common disorder, but most cases are probably never diagnosed, or they may be misdiagnosed as PCOS.”
BackgroundInfluentialNordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205
Self-citationHagenfeldt, K., Janson, P. O., Holmdahl, G., Falhammar, H., Filipsson, H., Frisen, L., Thoren, M., & Nordenskjold, A. (2008) · Human Reproduction · doi:10.1093/humrep/den118 · Cited by 205
Self-citationLong Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204
Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196
Self-citationHeart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men.
Shaper, A. G., Wannamethee, G., Macfarlane, P. W., & Walker, M. (1993) · Heart · doi:10.1136/hrt.70.1.49 · Cited by 196 · cited 1×
“An elevated heart rate, a risk factor for cardiovascular and noncardiovascular death independent of other cardiovascular risk factors [152–154], has been shown to be increased in a cohort of classic CAH and NCAH males C30 years, compared to controls [10].”
BackgroundAdult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia
Urban, M. D., Lee, P. A., & Migeon, C. J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812212992505 · Cited by 196 · cited 1×
“fertility, but it is from the 1970s when no genetic confirmation of the diagnosis was possible [91].”
BackgroundGastaud, F., Bouvattier, C., Duranteau, L., Brauner, R., Thibaud, E., Kutten, F., & Bougnères, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1757 · Cited by 192
Casteràs, A., De Silva, P., Rumsby, G., & Conway, G. S. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03563.x · Cited by 190
Testicular adrenal rest tumours in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Otten, B. J., Stikkelbroeck, M. M. L., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.007 · Cited by 187
Gidlöf, S., Falhammar, H., Thilén, A., von Döbeln, U., Ritzén, M., Wedell, A., & Nordenström, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70007-x · Cited by 187
Self-citationMoran, C., Azziz, R., Carmina, E., Dewailly, D., Fruzzetti, F., Ibañez, L., Knochenhauer, E. S., Marcondes, J. A. M., Mendonca, B. B., Pignatelli, D., et al. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.108020 · Cited by 185
Völkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1005 · Cited by 184 · cited 1×
“Most studies report an increased body mass index (BMI) in adults and children with CAH [12, 60, 87, 96, 110, 114, 117, 120, 122–126], but not in all [10, 65, 113, 127, 128].”
BackgroundThe relationship between resting heart rate and all-cause, cardiovascular and cancer mortality
Mensink, G. B. M., & Hoffmeister, H. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015465 · Cited by 179 · cited 1×
“An elevated heart rate, a risk factor for cardiovascular and noncardiovascular death independent of other cardiovascular risk factors [152–154], has been shown to be increased in a cohort of classic CAH and NCAH males C30 years, compared to controls [10].”
BackgroundIncidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Gregianin, M., Macri’, C., & Boscaro, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4501 · Cited by 177 · cited 1×
“5 % of the patients with adrenal incidentalomas to be affected byCAH [183], and some have reported that their finding of 9.”
BackgroundReproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0062 · Cited by 174 · cited 3×
“0 % stillborn infants at term appears to be similar to population data [49, 50].”
BackgroundHepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography
Rockall, A., Sohaib, S., Evans, D., Kaltsas, G., Isidori, A., Monson, J., Besser, G., Grossman, A., & Reznek, R. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490543 · Cited by 172 · cited 1×
“NAFLD has been found in endogenous Cushing’s syndrome [141], long-term glucocorticoid therapy [142], and PCOS [143].”
BackgroundQuality of life in 70 women with disorders of sex development
Johannsen, T. H., Ripa, C. P. L., Mortensen, E. L., & Main, K. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02294 · Cited by 171 · cited 1×
“Varying degrees of impaired QoL have been described [59, 60, 74, 79, 93–96].”
MethodHigh prevalence of reduced fecundity in men with congenital adrenal hyperplasia
Reisch, N., Flade, L., Scherr, M., Rottenkolber, M., Pedrosa Gil, F., Bidlingmaier, M., Wolff, H., Schwarz, H.-P., Quinkler, M., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1414 · Cited by 170
Falhammar, H., Nyström, H. F., Ekström, U., Granberg, S., Wedell, A., & Thorén, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0828 · Cited by 170
Self-citationFalhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Self-citationCharmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164
Nordenström, A., Frisén, L., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2639 · Cited by 161
Self-citationFertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency.
Feldman, S., Billaud, L., Thalabard, J. C., Raux-Demay, M. C., Mowszowicz, I., Kuttenn, F., & Mauvais-Jarvis, P. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1310999 · Cited by 155
Hormonally induced transformation of adrenal into myeloid tissue.
Selye, H., & STONE, H. (1950) · PubMed · Cited by 154
Kuhnle, U., Bullinger, M., & Schwarz, H. P. (1995) · European Journal of Pediatrics · doi:10.1007/bf02276713 · Cited by 153
Fractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151
Self-citationThilén, A., Nordenström, A., Hagenfeldt, L., von Döbeln, U., Guthenberg, C., & Larsson, A. (1998) · PEDIATRICS · doi:10.1542/peds.101.4.e11 · Cited by 151
Self-citationJääskeläinen, J., Levo, A., Voutilainen, R., & Partanen, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4271 · Cited by 149 · cited 1×
“The genotype-phenotype correlation in CAH is generally good [45, 46], especially for the genotypes for SW and NCAH, but the phenotypic variability is larger in the SV form [47, 48].”
BackgroundInsulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
Speiser, P. W., Serrat, J., New, M. I., & Gertner, J. M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464643 · Cited by 143 · cited 1×
“Most reports have shown decreased insulin sensitivity in CAH [10, 65, 125, 129–135], but none has so far reported increased type 2 diabetes [54].”
BackgroundClaahsen-van der Grinten, H. L., Sweep, F. C. G. J., Blickman, J. G., Hermus, A. R. M. M., & Otten, B. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0201 · Cited by 142 · cited 1×
“TARTs have been reported in all ages, down to children 6 years of age [165, 166] and have even been noted at autopsy in newly born CAH boys [167].”
BackgroundKoetz, K. R., Ventz, M., Diederich, S., & Quinkler, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2036 · Cited by 139 · cited 2×
“Longer-acting glucocorticoids seemed to result in a higher risk of negative effects on BMD than hydrocortisone [55, 109, 114], and the glucocorticoid dose appeared to be negatively correlated with BMD in some [107, 109, 110, 119], but not all studies [12, 55, 106, 111, 114–118].”
BackgroundResultClaahsen-van der Grinten, H. L., Otten, B. J., Takahashi, S., Meuleman, E. J. H., Hulsbergen-van de Kaa, C., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1311 · Cited by 139 · cited 17×
“The highest prevalence of TARTs reported was 86–94 % [86, 88], while others have reported lower frequencies, probably reflecting differences in the mode of detection (palpation, ultrasound, or MRI) and the age of patients [60, 85, 87, 89– 91, 158, 169–172].”
ResultInfluentialStikkelbroeck, N. M. M. L., Oyen, W. J. G., van der Wilt, G.-J., Hermus, A. R. M. M., & Otten, B. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021074 · Cited by 138 · cited 1×
“Most studies of CAH using DXA have found increased fat mass [110, 113, 117, 118, 128].”
BackgroundCongenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues
Ogilvie, C. M., Crouch, N. S., Rumsby, G., Creighton, S. M., Liao, L., & Con Way, G. S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02410.x · Cited by 136 · cited 1×
“In Europe, prednisolone appears to be the preferred glucocorticoid [10, 28, 59–61]while, in theUSA, prednisolone, dexamethasone, and hydrocortisone are each used in one-third of the cases [12].”
BackgroundKrone, N., Wachter, I., Stefanidou, M., Roscher, A. A., & Schwarz, H. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01359.x · Cited by 135 · cited 6×
“The majority do not need to change their regular glucocorticoid and mineralocorticoid doses [72].”
BackgroundInfluentialObesity in 21-hydroxylase deficient patients
Cornean, R. E., Hindmarsh, P. C., & Brook, C. G. D. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.3.261 · Cited by 135 · cited 1×
“Most studies report an increased body mass index (BMI) in adults and children with CAH [12, 60, 87, 96, 110, 114, 117, 120, 122–126], but not in all [10, 65, 113, 127, 128].”
Backgroundvan der Kamp, H. J., Slijper, F. M. E., & Bullinger, M. (1996) · European Journal of Pediatrics · doi:10.1007/bf01957920 · Cited by 134
Sartorato, P., Zulian, E., Benedini, S., Mariniello, B., Schiavi, F., Bilora, F., Pozzan, G., Greggio, N., Pagnan, A., Mantero, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1711 · Cited by 132
Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Merke, D. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2417 · Cited by 132 · cited 1×
“Some clinicians advocate reverse circadian dosing to improve androgen control [62]; however, we and others normally try to avoid having the highest dose at nighttime because we believe it may affect sleep negatively and may possibly result in worse cardiovascular and metabolic longterm outcomes.”
BackgroundVerma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03636.x · Cited by 126
Claahsen-van der Grinten, H. L., Otten, B. J., Sweep, F. C. G. J., Span, P. N., Ross, H. A., Meuleman, E. J. H., & Hermus, A. R. M. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0337 · Cited by 125
Pall, M., Azziz, R., Beires, J., & Pignatelli, D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.025 · Cited by 123 · cited 3×
“Women with both classic CAH [17] and NCAH [18, 19] may develop PCO.”
BackgroundGidlöf, S., Wedell, A., Guthenberg, C., von Döbeln, U., & Nordenström, A. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.5321 · Cited by 119
Self-citationBouvattier, C., Esterle, L., Renoult-Pierre, P., de la Perrière, A. B., Illouz, F., Kerlan, V., Pascal-Vigneron, V., Drui, D., Christin-Maitre, S., Galland, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4124 · Cited by 116
Martinez-Aguayo, A., Rocha, A., Rojas, N., García, C., Parra, R., Lagos, M., Valdivia, L., Poggi, H., & Cattani, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0383 · Cited by 114 · cited 1×
“TARTs have been reported in all ages, down to children 6 years of age [165, 166] and have even been noted at autopsy in newly born CAH boys [167].”
BackgroundBone mineral density and body composition in congenital adrenal hyperplasia.
Cameron, F. J., Kaymakci, B., Byrt, E. A., Ebeling, P. R., Warne, G. L., & Wark, J. D. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608286 · Cited by 114 · cited 2×
“Most studies report an increased body mass index (BMI) in adults and children with CAH [12, 60, 87, 96, 110, 114, 117, 120, 122–126], but not in all [10, 65, 113, 127, 128].”
BackgroundTestis Sparing Surgery for Steroid Unresponsive Testicular Tumors of the Adrenogenital Syndrome
Walker, B. R., Skoog, S. J., Winslow, B. H., Canning, D. A., & Tank, E. S. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65023-7 · Cited by 113 · cited 1×
“The results of surgery on fertility have been highly variable [174–176] and, in one of these studies, the recommendation was that surgery is only indicated for relief of pain and discomfort caused by the TARTs [176].”
ResultRoche, E. F., Charmandari, E., Dattani, M. T., & Hindmarsh, P. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01757.x · Cited by 113 · cited 2×
“correlated with the degree of obesity in some studies [145, 149], whereas obesity was not able to predict hypertension in another study [148].”
BackgroundResultAvila, N. A., Premkumar, A., Shawker, T. H., Jones, J. V., Laue, L., & Cutler, G. B. (1996) · Radiology · doi:10.1148/radiology.198.1.8539414 · Cited by 112 · cited 1×
“The highest prevalence of TARTs reported was 86–94 % [86, 88], while others have reported lower frequencies, probably reflecting differences in the mode of detection (palpation, ultrasound, or MRI) and the age of patients [60, 85, 87, 89– 91, 158, 169–172].”
BackgroundHelleday, J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.933 · Cited by 111 · cited 1×
“Most studies report an increased body mass index (BMI) in adults and children with CAH [12, 60, 87, 96, 110, 114, 117, 120, 122–126], but not in all [10, 65, 113, 127, 128].”
BackgroundStrandqvist, A., Falhammar, H., Lichtenstein, P., Hirschberg, A. L., Wedell, A., Norrby, C., Nordenskjöld, A., Frisén, L., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3326 · Cited by 111
Self-citationHagenfeldt, K., Martin Ritzen, E., Ringertz, H., Helleday, J., & Carlstrom, K. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430667 · Cited by 110 · cited 2×
“Longer-acting glucocorticoids seemed to result in a higher risk of negative effects on BMD than hydrocortisone [55, 109, 114], and the glucocorticoid dose appeared to be negatively correlated with BMD in some [107, 109, 110, 119], but not all studies [12, 55, 106, 111, 114–118].”
BackgroundResultAvila, N. A., Premkumar, A., & Merke, D. P. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.172.4.10587136 · Cited by 109 · cited 1×
“2 cm [173].”
Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Bachelot, A., Plu-Bureau, G., Thibaud, E., Laborde, K., Pinto, G., Samara, D., Nihoul-Fékété, C., Kuttenn, F., Polak, M., & Touraine, P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098017 · Cited by 106
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106 · cited 10×
“The likely explanation is that patients with congenital disorders have never experienced a time without their disorder, in contrast to patients with an acquired disorder [54].”
BackgroundMethodResultInfluentialSelf-citationKing, J. A., Wisniewski, A. B., Bankowski, B. J., Carson, K. A., Zacur, H. A., & Migeon, C. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0745 · Cited by 104 · cited 1×
“Most studies using DXA have reported impaired BMD values in adult CAH [12, 55, 60, 96, 106–114], but a few have shown normal BMD [115– 118].”
BackgroundFitness, J., Dixit, N., Webster, D., Torresani, T., Pergolizzi, R., Speiser, P. W., & Day, D. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5550 · Cited by 103 · cited 1×
“[40] 1999 New Zealand CYP21A2 mutation analysis 603 Caucasians (78 %)”
BackgroundNermoen, I., Rørvik, J., Holmedal, S. H., Hykkerud, D. L., Fougner, K. J., Svartberg, J., Husebye, E. S., & Løvås, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04151.x · Cited by 103
Falhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103 · cited 10×
“Moreover, we demonstrated impaired insulin sensitivity only in patients over 30 year of age [10, 28, 136].”
BackgroundResultInfluentialSelf-citationClinical Outcomes in Adrenal Incidentaloma: Experience From one Center
Patrova, J., Jarocka, I., Wahrenberg, H., & Falhammar, H. (2015) · Endocrine Practice · doi:10.4158/ep15618.or · Cited by 101
Self-citationMarino, R., Ramirez, P., Galeano, J., Perez Garrido, N., Rocco, C., Ciaccio, M., Warman, D. M., Guercio, G., Chaler, E., Maceiras, M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04123.x · Cited by 98
Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia
Lo, J. C., & Grumbach, M. M. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70027-6 · Cited by 98 · cited 2×
“Pregnancies have been reported to be basically normal and uneventful in CAH women [67, 72, 75, 78].”
BackgroundFalhammar, H., Butwicka, A., Landén, M., Lichtenstein, P., Nordenskjöld, A., Nordenström, A., & Frisén, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3707 · Cited by 98
Self-citationBaumgartner-Parzer, S. M., Nowotny, P., Heinze, G., Waldhäusl, W., & Vierhapper, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1728 · Cited by 97 · cited 1×
“[42] 2005 Vienna, Austria CYP21A2 mutation analysis 200 Caucasians (50 % Yugoslavs) Estimated 0.”
Bone density in young patients with congenital adrenal hyperplasia
Mora, S., Saggion, F., Russo, G., Weber, G., Bellini, A., Prinster, C., & Chiumello, G. (1996) · Bone · doi:10.1016/8756-3282(96)00003-8 · Cited by 95 · cited 1×
“In contrast, some studies have shown a similar frequency of osteoporosis or decreased BMD in NCAH compared to classic CAH [12, 96, 116, 119].”
ResultLivadas, S., Dracopoulou, M., Dastamani, A., Sertedaki, A., Maniati‐Christidi, M., Magiakou, A. ‐., Kanaka‐Gantenbein, C., Chrousos, G. P., & Dacou‐Voutetakis, C. (2015) · Clinical Endocrinology · doi:10.1111/cen.12543 · Cited by 92 · cited 6×
“It has been estimated that between 2 and 11 % of NCAH cases will be missed using this approach— at least in adults [14, 15, 32].”
BackgroundInfluentialEffects of testosterone on Type 2 diabetes and components of the metabolic syndrome
JONES, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 92 · cited 1×
“Supraphysiological glucocorticoid doses are often claimed to be the reason for insulin resistance in CAH, but high androgen levels in females and low testosterone levels in males can result in insulin resistance [138, 139].”
BackgroundJääskeläinen, J., & Voutilainen, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8620871.x · Cited by 92 · cited 1×
“Longer-acting glucocorticoids seemed to result in a higher risk of negative effects on BMD than hydrocortisone [55, 109, 114], and the glucocorticoid dose appeared to be negatively correlated with BMD in some [107, 109, 110, 119], but not all studies [12, 55, 106, 111, 114–118].”
ResultReisch, N., Scherr, M., Flade, L., Bidlingmaier, M., Schwarz, H.-P., Müller-Lisse, U., Reincke, M., Quinkler, M., & Beuschlein, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1929 · Cited by 92
Völkl, T. M. K., Simm, D., Dötsch, J., Rascher, W., & Dörr, H. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1069 · Cited by 91 · cited 2×
“correlated with the degree of obesity in some studies [145, 149], whereas obesity was not able to predict hypertension in another study [148].”
BackgroundResultBachega, T. A. S. S., Billerbeck, A. E. C., Marcondes, J. A. M., Madureira, G., Arnhold, I. J. P., & Mendonca, B. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00995.x · Cited by 90 · cited 6×
“It has been estimated that between 2 and 11 % of NCAH cases will be missed using this approach— at least in adults [14, 15, 32].”
BackgroundMethodInfluentialGussinyé, M., Carrascosa, A., Potau, N., Enrubia, M., Vicens-Calvet, E., Ibáñez, L., & Yeste, D. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.671 · Cited by 90 · cited 1×
“Most studies report an increased body mass index (BMI) in adults and children with CAH [12, 60, 87, 96, 110, 114, 117, 120, 122–126], but not in all [10, 65, 113, 127, 128].”
BackgroundChakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maître, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0887 · Cited by 90
Jääskeläinen, J., & Voutilainen, R. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb01213.x · Cited by 89 · cited 1×
“In a few publications, no difference from controls was found [97–99] and, in one study, even a better QoL compared to controls was reported [100].”
ResultNermoen, I., Husebye, E. S., Svartberg, J., & Løvås, K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0284 · Cited by 89 · cited 2×
“Varying degrees of impaired QoL have been described [59, 60, 74, 79, 93–96].”
BackgroundMethodHeight, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia
Paganini, C., Radetti, G., Livieri, C., Braga, V., Migliavacca, D., & Adami, S. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053253 · Cited by 87 · cited 2×
“This has also been demonstrated in children [120].”
BackgroundResultReisch, N., Rottenkolber, M., Greifenstein, A., Krone, N., Schmidt, H., Reincke, M., Schwarz, H.-P., & Beuschlein, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3181 · Cited by 82
Sciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82 · cited 2×
“Most studies using DXA have reported impaired BMD values in adult CAH [12, 55, 60, 96, 106–114], but a few have shown normal BMD [115– 118].”
BackgroundResultBone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia
Falhammar, H., Filipsson Nyström, H., Wedell, A., Brismar, K., & Thorén, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0865 · Cited by 82 · cited 4×
“Longer-acting glucocorticoids seemed to result in a higher risk of negative effects on BMD than hydrocortisone [55, 109, 114], and the glucocorticoid dose appeared to be negatively correlated with BMD in some [107, 109, 110, 119], but not all studies [12, 55, 106, 111, 114–118].”
BackgroundResultInfluentialSelf-citationBone turnover and bone mineral density in patients with congenital adrenal hyperplasia
Guo, C., Weetman, A. P., & Eastell, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00851.x · Cited by 79 · cited 1×
“Longer-acting glucocorticoids seemed to result in a higher risk of negative effects on BMD than hydrocortisone [55, 109, 114], and the glucocorticoid dose appeared to be negatively correlated with BMD in some [107, 109, 110, 119], but not all studies [12, 55, 106, 111, 114–118].”
ResultHan, T. S., Krone, N., Willis, D. S., Conway, G. S., Hahner, S., Rees, D. A., Stimson, R. H., Walker, B. R., Arlt, W., Ross, R. J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0128 · Cited by 79 · cited 1×
“The choice of glucocorticoid preparation has been reported to affect QoL, with prednisolone or dexamethasone resulting in a worse QoL in one study [101], while another including only males, showed worse outcomes with hydrocortisone/cortisone acetate than in controls and patients treated with prednisolone [99].”
ResultReisch, N., Hahner, S., Bleicken, B., Flade, L., Pedrosa Gil, F., Loeffler, M., Ventz, M., Hinz, A., Beuschlein, F., Allolio, B., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03920.x · Cited by 78
Mortality in patients with congenital adrenal hyperplasia: a cohort study
Swerdlow, A. J., Higgins, C. D., Brook, C. G. D., Dunger, D. B., Hindmarsh, P. C., Price, D. A., & Savage, M. O. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70060-5 · Cited by 77 · cited 1×
“Only two studies have reported on mortality in diagnosed CAH individuals [53, 121].”
BackgroundNewborn screening for congenital adrenal hyperplasia in New Zealand
Cutfield, W. S., & WEBSTER, D. R. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70513-9 · Cited by 77
Saygılı, F., Oge, A., & Yilmaz, C. (2005) · Hormone Research in Paediatrics · doi:10.1159/000086363 · Cited by 75 · cited 1×
“Most reports have shown decreased insulin sensitivity in CAH [10, 65, 125, 129–135], but none has so far reported increased type 2 diabetes [54].”
BackgroundMonitoring of Therapy in Congenital Adrenal Hyperplasia
Dauber, A., Kellogg, M., & Majzoub, J. A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146035 · Cited by 72
Stikkelbroeck, N. M. L., Hermus, A. M. M., Schouten, D., Suliman, H., Jager, G., Braat, D. M., & Otten, B. (2004) · European Radiology · doi:10.1007/s00330-004-2329-x · Cited by 71 · cited 2×
“Women with both classic CAH [17] and NCAH [18, 19] may develop PCO.”
BackgroundPituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency
Jääskeläinen, J., Kiekara, O., Hippeläinen, M., & Voutilainen, R. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343671 · Cited by 71 · cited 2×
“The highest prevalence of TARTs reported was 86–94 % [86, 88], while others have reported lower frequencies, probably reflecting differences in the mode of detection (palpation, ultrasound, or MRI) and the age of patients [60, 85, 87, 89– 91, 158, 169–172].”
BackgroundJÄÄSKELÄINEN, J., HIPPELÄINEN, M., KIEKARA, O., & VOUTILAINEN, R. (2000) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079008687.x · Cited by 70 · cited 1×
“The pregnancy rate among women with classic CAH has been repeatedly found to be decreased, compared with both age-matched controls [67, 70–74] and fertility in the general population [60, 75].”
ResultSmeets, E. E. J. W., Span, P. N., van Herwaarden, A. E., Wevers, R. A., Hermus, A. R. M. M., Sweep, F. C. G. J., & Claahsen-van der Grinten, H. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2036 · Cited by 70
Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency
Charmandari, E., Eisenhofer, G., Mehlinger, S. L., Carlson, A., Wesley, R., Keil, M. F., Chrousos, G. P., New, M. I., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8664 · Cited by 70
Williams, R. M., Deeb, A., Ong, K. K., Bich, W., Murgatroyd, P. R., Hughes, I. A., & Acerini, C. L. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03587.x · Cited by 69
Weise, M., Mehlinger, S. L., Drinkard, B., Rawson, E., Charmandari, E., Hiroi, M., Eisenhofer, G., Yanovski, J. A., Chrousos, G. P., & Merke, D. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030634 · Cited by 67
Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy.
Itoh, S., Igarashi, M., Tsukada, Y., & Ichinoe, A. (1977) · PubMed · Cited by 66
Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013
Heather, N. L., Seneviratne, S. N., Webster, D., Derraik, J. G. B., Jefferies, C., Carll, J., Jiang, Y., Cutfield, W. S., & Hofman, P. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3168 · Cited by 65 · cited 1×
“5 million newborns [6, 34–36].”
Molecular Genetics of 21- Hydroxylase Deficiency
Wedell, A. (2011) · Endocrine Development · doi:10.1159/000321223 · Cited by 64 · cited 1×
“The gene encoding 21-hydroxylase is named CYP21A2 and has been well characterized [44].”
BackgroundZhang, H., Yang, J., Zhang, M., Liu, C., Xu, M., Li, X., Yang, S.-Y., & Li, X.-Y. (2010) · Endocrine · doi:10.1007/s12020-010-9382-9 · Cited by 64
Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls
Varness, T. S., Allen, D. B., & Hoffman, G. L. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.035 · Cited by 61 · cited 1×
“Since the introduction of neonatal screening in many countries, classic CAH is now usually diagnosed in the neonatal period, however, occasional classic CAH patients may still be missed in the neonatal screening [25, 26].”
BackgroundClaahsen-van der Grinten, H. L., Dehzad, F., Kamphuis-van Ulzen, K., & de Korte, C. L. (2014) · Hormone Research in Paediatrics · doi:10.1159/000365570 · Cited by 61
Christiansen, P., Mølgaard, C., & Müller, J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075588 · Cited by 61 · cited 1×
“Most studies of CAH using DXA have found increased fat mass [110, 113, 117, 118, 128].”
BackgroundZERAH, M., UESHIBA, H., WOOD, E., SPEISER, P. W., CRAWFORD, C., MCDONALD, T., PAREIRA, J., GRUEN, D., & NEW, M. I. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1662 · Cited by 59 · cited 1×
“[39] 1990 New York City, US Salivary 17OHP 249 Ashkenazi Jews 2 of 62 (3.”
BackgroundPlasma Homocysteine Levels in Polycystic Ovary Syndrome and Congenital Adrenal Hyperplasia
BAYRAKTAR, F., DERELI, D., ÖZGEN, A. G., & YILMAZ, C. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.601 · Cited by 55 · cited 2×
“One study of females with NCAH found similar insulin sensitivity in patients and controls [137].”
BackgroundLong-Term Outcome of Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
Mnif, M. F., Kamoun, M., Mnif, F., Charfi, N., Kallel, N., Naceur, B. B., Rekik, N. M., Abid, M., Mnif, Z., Sfar, M. H., et al. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31824369e4 · Cited by 54
Testicular Hilar Nodules in Adrenogenital Syndrome: The Nature of the Nodules
SHANKLIN, D. R. (1963) · American Journal of Diseases of Children · doi:10.1001/archpedi.1963.02080050245001 · Cited by 53 · cited 1×
“TARTs have been reported in all ages, down to children 6 years of age [165, 166] and have even been noted at autopsy in newly born CAH boys [167].”
BackgroundEl‐Maouche, D., Collier, S., Prasad, M., Reynolds, J. C., & Merke, D. P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12507 · Cited by 53 · cited 3×
“Fracture prevalence has occasionally been reported in CAH [55, 106, 112, 114], and patients with NCAH seem to have experienced fewer fractures than those with the more severe forms [106, 112].”
BackgroundResultNordenström, A., Marcus, C., Axelson, M., Wedell, A., & Ritzén, E. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5584 · Cited by 52
Self-citationNon-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Gilban, D. L. S., Alves Junior, P. A. G., & Beserra, I. C. R. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0107-2 · Cited by 51 · cited 1×
“Varying degrees of impaired QoL have been described [59, 60, 74, 79, 93–96].”
MethodGreen-Golan, L., Yates, C., Drinkard, B., VanRyzin, C., Eisenhofer, G., Weise, M., & Merke, D. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0493 · Cited by 50
Hirvikoski, T., Lindholm, T., Lajic, S., & Nordenström, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02260.x · Cited by 49
Self-citationElevated 17-hydroxyprogesterone serum values in male patients with acne
Placzek, M., Arnold, B., Schmidt, H., Gaube, S., Keller, E., Plewig, G., & Degitz, K. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.07.014 · Cited by 49
Völkl, T. M. K., Simm, D., Körner, A., Rascher, W., Kiess, W., Kratzsch, J., & Dörr, H. G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0770 · Cited by 49 · cited 2×
“Most studies report an increased body mass index (BMI) in adults and children with CAH [12, 60, 87, 96, 110, 114, 117, 120, 122–126], but not in all [10, 65, 113, 127, 128].”
BackgroundMouritsen, A., Jørgensen, N., Main, K. M., Schwartz, M., & Juul, A. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00967.x · Cited by 48 · cited 1×
“TARTs have mostly been reported in classic CAH and may be more prevalent in the more severe pheno- and genotypes [158, 170], but males with NCAH have been reported to have them aswell [86].”
BackgroundTiryaki, T., Aycan, Z., Hücümenoğlu, S., & Atayurt, H. (2005) · Pediatric Surgery International · doi:10.1007/s00383-005-1547-x · Cited by 47
Harrington, J., Peña, A. S., Gent, R., Hirte, C., & Couper, J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04309.x · Cited by 46 · cited 1×
“However, in a cohort of CAH adolescents, no increased intima-media thickness was seen, but, instead, another surrogate marker for atherosclerosis, vascular endothelial and smooth muscle dysfunction, was demonstrated [151].”
BackgroundPignatelli, D. (2013) · Frontiers of Hormone Research · doi:10.1159/000342179 · Cited by 44 · cited 1×
“As a consequence of chronic androgen excess on the hypothalamic-pituitaryovarian axis, by alteration of gonadotropin release or direct effects on the ovaries, women with CAH may develop a secondary PCOS-like physiology [16].”
BackgroundAmr, N. H., Ahmed, A. Y., & Ibrahim, Y. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0148-8 · Cited by 44 · cited 1×
“In both children and young adults with CAH, intima-media thickness, a predictor of clinical arteriosclerosis and associated with cardiovascular risk, has been found to be increased compared to controls [129, 135].”
ResultFalhammar, H., Nyström, H. F., & Thorén, M. C. (2014) · Endocrine · doi:10.1007/s12020-013-0161-2 · Cited by 43 · cited 1×
“The choice of glucocorticoid preparation has been reported to affect QoL, with prednisolone or dexamethasone resulting in a worse QoL in one study [101], while another including only males, showed worse outcomes with hydrocortisone/cortisone acetate than in controls and patients treated with prednisolone [99].”
ResultSelf-citationVoice characteristics in women with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
Nygren, U., Södersten, M., Falhammar, H., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03347.x · Cited by 43
Self-citationNermoen, I., Brønstad, I., Fougner, K. J., Svartberg, J., Øksnes, M., Husebye, E. S., & Løvås, K. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0196 · Cited by 43 · cited 5×
“This may indicate nonalcoholic fatty liver disease (NAFLD), but others have not been able to confirm this finding [113].”
BackgroundResultInfluentialMooij, C. F., Kroese, J. M., Sweep, F. C. G. J., Hermus, A. R. M. M., & Tack, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024204 · Cited by 42
Malouf, M. A., Inman, A. G., Carr, A. G., Franco, J., & Brooks, L. M. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/253465 · Cited by 41 · cited 1×
“In a few publications, no difference from controls was found [97–99] and, in one study, even a better QoL compared to controls was reported [100].”
ResultFIET, J., GUEUX, B., RAUXDEMAY, M.-C., KUTTENN, F., VEXIAU, P., BRERAULT, J., COUILLIN, P., GALONS, H., VILLETTE, J., JULIEN, R., et al. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-542 · Cited by 40 · cited 2×
“Some degree of aldosterone insufficiency can be found in all individuals with 21-hydroxylase deficiency, and also in patients with NCAH [9].”
Backgroundde Silva, K. S. H., Kanumakala, S., Brown, J. J., Jones, C. L., & Warne, G. L. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.8.1089 · Cited by 39
Observation of hypertension in children with 21-hydroxylase deficiency: A preliminary report
Nebesio, T. D., & Eugster, E. A. (2006) · Endocrine · doi:10.1007/s12020-006-0005-4 · Cited by 39 · cited 2×
“correlated with the degree of obesity in some studies [145, 149], whereas obesity was not able to predict hypertension in another study [148].”
BackgroundResultGiant Bilateral Myelolipomas in a Man with Congenital Adrenal Hyperplasia
McGeoch, S. C., Olson, S., Krukowski, Z. H., & Bevan, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2373 · Cited by 38 · cited 1×
“More than half of the tumors have been reported to be myelolipomas [158], which, occasionally, can be huge [178].”
BackgroundZimmermann, A., Grigorescu-Sido, P., AlKhzouz, C., Patberg, K., Bucerzan, S., Schulze, E., Zimmermann, T., Rossmann, H., Geiss, H.-C., Lackner, K. J., et al. (2010) · Hormone Research in Paediatrics · doi:10.1159/000313368 · Cited by 38 · cited 1×
“Increased triglycerides in nonobese children [140] and lower HDL in children and adults [132], compared to controls, have also been reported.”
Patocs, A., Toth, M., Barta, C., Sasvari-Szekely, M., Varga, I., Szucs, N., Jakab, C., Glaz, E., & Racz, K. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470349 · Cited by 38 · cited 1×
“How frequently an adrenal incidentaloma presents symptoms of NCAH is unclear, but there are several reports of NCAH diagnoses as the result of the work-up of these tumors [24, 29, 180–182, 185].”
BackgroundNon-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?
Falhammar, H. (2014) · Endocrine · doi:10.1007/s12020-013-0162-1 · Cited by 38 · cited 4×
“In some of these cases, the diagnosis of CAH, both classic and NCAH, was made on the urinary steroid profile sampled in the work-up of suspected adrenocortical cancer [24, 29, 185].”
BackgroundInfluentialSelf-citationStoupa, A., González-Briceño, L., Pinto, G., Samara-Boustani, D., Thalassinos, C., Flechtner, I., Beltrand, J., Bidet, M., Simon, A., Piketty, M., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369901 · Cited by 37 · cited 1×
“Nevertheless, they have a partial cortisol insufficiency [14, 32, 51], mostly very mild, but up to one-third of them have an ACTH-stimulated cortisol level below 400 nmol/L and 60 % a level of less than 500 nmol/L.”
BackgroundLate onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction.
Birnbaum, M. D., & Rose, L. I. (1984) · PubMed · Cited by 37
Paula, F. J. A., Gouveia, L. M. F. B., Paccola, G. M. G. F., Piccinato, C., Moreira, A., & Foss, M. (1994) · Hormone and Metabolic Research · doi:10.1055/s-2007-1001755 · Cited by 35 · cited 1×
“Most reports have shown decreased insulin sensitivity in CAH [10, 65, 125, 129–135], but none has so far reported increased type 2 diabetes [54].”
BackgroundFALHAMMAR, H., FILIPSSON, H., HOLMDAHL, G., JANSON, P.-O., NORDENSKJÖLD, A., HAGENFELDT, K., & THORÉN, M. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-312 · Cited by 35
Self-citationIncidentally Discovered Adrenal Tumors: Endocrine and Scintographic Correlates
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Gregianin, M., Macri, C., & Boscaro, M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62838-6 · Cited by 34
Dumić, M., Brkljačić, L., Speiser, P. W., Wood, E., Crawford, C., Plavšić, V., Baničeviác, M., Radmanović, S., Radica, A., Kaštelan, A., et al. (1990) · Acta Endocrinologica · doi:10.1530/acta.0.1220703 · Cited by 33 · cited 1×
“[38] 1990 Zagreb, Croatia and Beograd, Serbia HLA genotype data Stimulated 17OHP 98 Croatians and Serbs Estimated 0.”
BackgroundFalhammar, H., Thoren, M., & Hagenfeldt, K. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345586 · Cited by 32 · cited 5×
“One woman with NCAH and gestational diabetes has been reported on in detail [18].”
BackgroundInfluentialSelf-citationBaumgartner‐Parzer, S. M., Pauschenwein, S., Waldhäusl, W., Pölzler, K., Nowotny, P., & Vierhapper, H. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01299.x · Cited by 32
Lipid profile in congenital adrenal hyperplasia
Botero, D., Arango, Á. I., Danon, M., & Lifshitz, F. (2000) · Metabolism · doi:10.1053/meta.2000.6261 · Cited by 32 · cited 1×
“Increased triglycerides in nonobese children [140] and lower HDL in children and adults [132], compared to controls, have also been reported.”
Blood Pressure in Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Hoepffner, W., Herrmann, A., Willgerodt, H., & Keller, E. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.5.705 · Cited by 28 · cited 1×
“Modest blood pressure elevations still within the normal range during daytime [146] and during hospital admission have been reported [147].”
Background[Clinically late virilism with excretion of pregnanetriol and insufficiency of cortisol production].
Decourt, J., Jayle, M. F., & Baulieu, E. E. (1957) · PubMed · Cited by 28
Riepe, F., Krone, N., Krüger, S., Sweep, F., Lenders, J., Dötsch, J., Mönig, H., Sippell, W., & Partsch, C.-J. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2005-865836 · Cited by 27
High carrier frequency of 21‐hydroxylase deficiency in Cyprus
Phedonos, A., Shammas, C., Skordis, N., Kyriakides, T., Neocleous, V, & Phylactou, L. (2013) · Clinical Genetics · doi:10.1111/cge.12153 · Cited by 25 · cited 1×
“[43] 2013 Nicosia, Cyprus CYP21A2 mutation analysis 300 Greeks Estimated 0.”
BackgroundKang, M. J., Kim, J. H., Lee, S. H., Lee, Y. A., Shin, C. H., & Yang, S. W. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-034 · Cited by 25
Ezquieta, B., Ruano, M. L. F., Dulín, E., Arnao, D. R., & Rodríguez, A. (2005) · Medicina Clínica · doi:10.1157/13080213 · Cited by 25
Malignancy associated with congenital adrenal hyperplasia
Duck, S. C. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80335-6 · Cited by 25 · cited 1×
“It has been speculated that individuals with CAH may have an increased risk for malignant tumors [161, 162], but cancer mortality has not been shown to be increased, compared to controls [53].”
BackgroundKrysiak, R. G., & Okopień, B. (2014) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0034-1382048 · Cited by 24 · cited 1×
“Metformin has recently been shown to improve not only glycemic control, but also 17OHP, testosterone, androstenedione, and DHEAS in eight women with NCAH and T2DM [68].”
BackgroundNagasaka, S., Kubota, K., Motegi, T., Hayashi, E., Ohta, M., Takahashi, K., Takahashi, T., Iwasaki, Y., Koike, M., Nishikawa, T., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.631456.x · Cited by 23 · cited 1×
“In some of these cases, the diagnosis of CAH, both classic and NCAH, was made on the urinary steroid profile sampled in the work-up of suspected adrenocortical cancer [24, 29, 185].”
BackgroundFalhammar, H., & Thoren, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347226 · Cited by 23 · cited 2×
“In some of these cases, the diagnosis of CAH, both classic and NCAH, was made on the urinary steroid profile sampled in the work-up of suspected adrenocortical cancer [24, 29, 185].”
BackgroundSelf-citationRefractory Acne and 21-Hydroxylase Deficiency in a Selected Group of Female Patients
Caputo, V., Fiorella, S., Curiale, S., Caputo, A., & Niceta, M. (2010) · Dermatology · doi:10.1159/000277608 · Cited by 21
Nygren, U., Nyström, H. F., Falhammar, H., Hagenfeldt, K., Nordenskjöld, A., & Södersten, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12226 · Cited by 21
Self-citationLiivak, K., & Tillmann, V. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.6.511 · Cited by 19 · cited 2×
“A small study on six SW children showed that their 24-h blood pressure increased when the highest dose of hydrocortisone was given in the evening [63].”
BackgroundMooij, C. F., Kapusta, L., Otten, B. J., & der Grinten, H. L. C. (2010) · Hormone Research in Paediatrics · doi:10.1159/000308891 · Cited by 17
Doleschall, M., Szabó, J. A., Pázmándi, J., Szilágyi, Á., Koncz, K., Farkas, H., Tóth, M., Igaz, P., Gláz, E., Prohászka, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107244 · Cited by 15 · cited 1×
“6 % CYP21A2 carriers with nonfunctioning adrenal incidentaloma was not different from that in healthy controls [184].”
BackgroundA case of androgen-secreting adrenal carcinoma with non-classical congenital adrenal hyperplasia
Varma, T., Panchani, R., Goyal, A., & Maskey, R. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.119585 · Cited by 14 · cited 1×
“Even though adrenocortical cancer is rare in CAH, there are occasional case reports on previously both diagnosed and undiagnosed classic CAH [162, 186] and on undiagnosedNCAH[187, 188].”
BackgroundNonclassical congenital adrenal hyperplasia: targets of treatment and transition.
McCann‐Crosby, B., Chen, M.-J., Lyons, S. K., Lin, Y., Axelrad, M. E., Dietrich, J. E., Sutton, V. R., Macias, C. G., Gunn, S., & Karaviti, L. P. (2014) · PubMed · Cited by 14
A Feminizing Adrenocortical Carcinoma in the Context of a Late Onset 21-Hydroxylase Deficiency
Libé, R., Arlt, W., Louiset, E., Waintrop, C., Guibourdenche, J., Sibony, M., Clauser, É., & Groussin, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1342 · Cited by 12
Hayashi, M., Kataoka, Y., Sugimura, Y., Kato, F., Fukami, M., Ogata, T., Homma, K., Hasegawa, T., Oiso, Y., Sasano, H., et al. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.231.75 · Cited by 10 · cited 1×
“Even though adrenocortical cancer is rare in CAH, there are occasional case reports on previously both diagnosed and undiagnosed classic CAH [162, 186] and on undiagnosedNCAH[187, 188].”
BackgroundSharquie, K. E., Noaimi, A. A., Saleh, B. O. M., & Anbar, Z. N. H. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4903 · Cited by 9 · cited 1×
“, patients with only one CYP21A2 allele mutated) has been seen in clinics treating severe acne [21–23].”
BackgroundFalhammar, H. (2010) · PubMed · Cited by 8
Self-citation[A study of 34 cases of adrenal incidentaloma].
Chervin, R. A., Danilowicz, K., Pitoia, F., Gomez, R. M., & Bruno, O. D. (2007) · PubMed · Cited by 8
Krysiak, R. G., & Okopień, B. (2013) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0033-1355383 · Cited by 7 · cited 1×
“Moreover, simvastatin also improved 17OHP, testosterone, androstenedione, and DHEAS in four women with NCAH and isolated hypercholesterolemia [69].”
BackgroundVaran (2000) · doi:10.1002/1096-911x(200007)35:1<88::aid-mpo18>3.0.co;2-i
Research works printed but not linked: 1
- D. Crecchio, Sopra un caso di apparenzi virili in una donna. I Morgagni 7, 154–188 (1865)
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationRushworth, R. L., Torpy, D. J., & Falhammar, H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807486 · Cited by 262
Self-citationMECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. W. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0124 · Cited by 151
Metadata
- Authors
- Falhammar, H., & Nordenström, A.
- Affiliations
- Karolinska University Hospital (SE)
- Corresponding author
- Falhammar, Henrik
- Venue
- Endocrine
- Published
- 2015-06-17
- Volume
- 50
- Issue
- 1
- Pages
- 32-50
- ISSN
- 0969-711X (ISSN-L)
- 1355-008X
- 1559-0100
- OpenAlex
- W1880577592
- Cited by
- 127
- References
- 200
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 9 · 2023: 14 · 2022: 12 · 2021: 15 · 2020: 10 · 2019: 12 · 2018: 15 · 2017: 10 · 2016: 8 · 2015: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Magnus Bergvall Foundation (2014-00070)
- Karolinska Institutet togheter with Stockholm County Council (20130614)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- non-classical congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 mutations, 17-hydroxyprogesterone, ACTH stimulation test, glucocorticoid therapy, hyperandrogenism, infertility, premature pubarche, testicular adrenal rest tumor, late complications, diagnosis
- MeSH terms
- Adrenal Hyperplasia, Congenital, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.